Target intelligence / Profile preview

Ras-related protein Rab-5B (RAB5B)

Target
RAB5B
Molecular classification
Small GTPase, Enzyme (GTP hydrolase), Ras superfamily, Rab family
01

Overview

Ras-related protein Rab-5B (RAB5B) is a member of the Rab family of small GTPases, classified within the Ras superfamily, and functions as a molecular switch regulating endocytic vesicle trafficking in eukaryotic cells[2][3][4]. RAB5B is specifically involved in the formation, transport, binding, and fusion of vesicles with early endosomes, thus playing essential roles in endocytosis, early endosome fusion, and recycling of cell surface molecules[2][3][4]. In lung cells, RAB5B has a specialized, noncanonical role in the processing and trafficking of surfactant proteins SP-B and SP-C, with pathogenic variants causing surfactant dysfunction disorders and interstitial lung disease[1]. In cancer biology, RAB5B regulates cell adhesion, migration, and signaling, with altered expression linked to metastasis, immune evasion, and drug resistance; it holds potential as both a biomarker and therapeutic target, though no direct inhibitors are currently used clinically[3]. RAB5B’s essential functions in membrane trafficking, signal transduction, and autophagy make it a central regulator of cellular homeostasis and disease[3][4].

Other names
Ras-related protein Rab-5BRAB5BRas-related protein Rab5B
02

Mechanism of action

Modulation/targeting of small GTPase function to alter vesicle trafficking or endocytosis (hypothetical; no approved drugs known targeting RAB5B directly[3])

03

Biological functions

EndocytosisVesicle traffickingEarly endosome fusionMembrane transportSignal transductionRegulation of autophagyRecycling of cell surface moleculesRegulation of surfactant protein processing (noncanonical, in lung)Regulation of cell adhesion and migration
04

Disease associations

CancerSurfactant dysfunction disorder (interstitial lung disease)Immune regulationPotential: other diseases involving vesicle trafficking defects
05

Safety considerations

Disruption of RAB5B function can cause failures in endocytosis and vesicle trafficking, with tissue-specific effects:In lung, dominant negative mutations disrupt surfactant protein maturation, causing interstitial lung disease[1]In cancer, modulation may affect normal cell processes due to broad roles in intracellular trafficking[3]
06

Biomarkers

RAB5B expression as a biomarker for cancer prognosis, tumor progression, and response to immune therapy[3]Correlation with immunotherapy biomarkers in tumors[3]RAB5B level reduction used in assessment of surfactant dysfunction disorder[1]

Beyond the preview

Go deeper on Ras-related protein Rab-5B (RAB5B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ras-related protein Rab-5B (RAB5B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call